Pfizer Breakthrough Growth Initiative
Description
Pfizer Breakthrough Growth Initiative provide funding to biotechnology companies.
Investor Profile
Pfizer Breakthrough Growth Initiative has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 67% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Post Ipo Equity, Series B rounds (top funding stages).
- Majority of deals are located in United States, Canada, Belgium.
- Strong thematic focus on Biotechnology, Therapeutics, Health Care.
Stage Focus
- Series A (33%)
- Post Ipo Equity (33%)
- Series B (33%)
Country Focus
- United States (33%)
- Canada (33%)
- Belgium (33%)
Industry Focus
- Biotechnology
- Therapeutics
- Health Care
- Pharmaceutical
- Biopharma
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.